Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and In Vivo Antiinflammatory Activity

John Buchanan co-authored an article titled "Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and In Vivo Antiinflammatory Activity" in the Journal of Medicinal Chemistry.